arabinofuranosyluracil and Chronic Illness

arabinofuranosyluracil has been researched along with Chronic Illness in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	10 (90.91)	18.2507
2000's	1 (9.09)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jo, HY; Kim, DS; Kim, HS; Kim, SY; Lee, CH; Lee, DK; Park, MS; Seok, JI	1
Conjeevaram, H; Di Bisceglie, AM; Fried, MW; Kleiner, D; Luciano, C; McKenzie, R; Park, Y; Sallie, R; Savarese, B; Tsokos, M	1
Swartz, MN	1
de Man, RA; Heijtink, RA; Niesters, HG; Schalm, SW	1
Brahams, D	1
Bari, A	1
Prince, AM	1
Gordon, M	1
Gaffey, MJ; Hoofnagle, JH; Kleiner, DE; McKenzie, R; Nichols, L; Sallie, R; Straus, SE; Tsokos, M	1
Chern, KC; Conrad, D; Holland, GN; Holsclaw, DS; Margolis, TP; Schwartz, LK	1
Chomel, B; Fourel, I; Fox, JJ; Hantz, O; Jacquet, C; Trepo, C; Watanabe, KA	1

Reviews

1 review(s) available for arabinofuranosyluracil and Chronic Illness

Article	Year
New nucleoside analogues for chronic hepatitis B. Journal of hepatology, 1995, Volume: 22, Issue:1 Suppl Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Drug Evaluation, Preclinical; Famciclovir; Hepatitis B; Humans; Lamivudine; Nucleosides; Zalcitabine	1995

Trials

2 trial(s) available for arabinofuranosyluracil and Chronic Illness

Article	Year
Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. The New England journal of medicine, 1995, Oct-26, Volume: 333, Issue:17 Topics: Acidosis, Lactic; Adult; Alanine Transaminase; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; DNA, Mitochondrial; DNA, Viral; Drugs, Investigational; Female; Hepatitis B; Humans; Jaundice; Liver; Liver Failure; Liver Transplantation; Male; Middle Aged; Pancreatitis; Peripheral Nervous System Diseases	1995
Deaths in US fialuridine trial. Lancet (London, England), 1994, Jun-11, Volume: 343, Issue:8911 Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Arabinofuranosyluracil; Cause of Death; Chronic Disease; Female; Hepatitis B; Humans; Male; Middle Aged; Survival Rate	1994

Article

Year

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

The New England journal of medicine, 1995, Oct-26, Volume: 333, Issue:17

Topics: Acidosis, Lactic; Adult; Alanine Transaminase; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; DNA, Mitochondrial; DNA, Viral; Drugs, Investigational; Female; Hepatitis B; Humans; Jaundice; Liver; Liver Failure; Liver Transplantation; Male; Middle Aged; Pancreatitis; Peripheral Nervous System Diseases

1995

Deaths in US fialuridine trial.

Lancet (London, England), 1994, Jun-11, Volume: 343, Issue:8911

Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Arabinofuranosyluracil; Cause of Death; Chronic Disease; Female; Hepatitis B; Humans; Male; Middle Aged; Survival Rate

1994

Other Studies

8 other study(ies) available for arabinofuranosyluracil and Chronic Illness

Article	Year
Long-term therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA. Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:6 Topics: Adult; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; DNA, Mitochondrial; Female; Hepatitis B, Chronic; Humans; Male; Middle Aged; Mitochondrial Myopathies; Time Factors	2009
Mitochondrial toxicity--new adverse drug effects. The New England journal of medicine, 1995, Oct-26, Volume: 333, Issue:17 Topics: Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Clinical Trials as Topic; DNA, Mitochondrial; Hepatitis B; Humans; Liver Failure	1995
Severe toxicity of fialuridine (FIAU) The New England journal of medicine, 1996, Apr-25, Volume: 334, Issue:17 Topics: Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Hepatitis B; Humans; Interferons; Nucleosides	1996
Severe toxicity of fialuridine (FIAU) The New England journal of medicine, 1996, Apr-25, Volume: 334, Issue:17 Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Hepatitis; Humans; Marmota; Pan troglodytes	1996
Severe toxicity of fialuridine (FIAU) The New England journal of medicine, 1996, Apr-25, Volume: 334, Issue:17 Topics: Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Cytarabine; Drug Approval; Hepatitis B; Humans	1996
Histopathologic changes associated with fialuridine hepatotoxicity. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 1997, Volume: 10, Issue:3 Topics: Adult; Antiviral Agents; Arabinofuranosyluracil; Chemical and Drug Induced Liver Injury; Chronic Disease; Clinical Trials, Phase II as Topic; Female; Hepatitis B; Humans; Liver; Male; Middle Aged; Randomized Controlled Trials as Topic	1997
Chronic varicella-zoster virus epithelial keratitis in patients with acquired immunodeficiency syndrome. Archives of ophthalmology (Chicago, Ill. : 1960), 1998, Volume: 116, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Aged; Antiviral Agents; Arabinofuranosyluracil; CD4 Lymphocyte Count; Chronic Disease; Epithelium, Corneal; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Keratitis, Dendritic; Male; Middle Aged; Retrospective Studies	1998
Inhibitory effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:3 Topics: Administration, Oral; Animals; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Cytarabine; Hepadnaviridae; Hepatitis, Viral, Animal; Uridine; Virus Replication	1990